CTRI/2017/11/010700已完成未知
Hemodynamic behaviour post liver transplant; A surrogate marker for graft function
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- ILBS
- 入组人数
- 95
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Acute and chronic liver failure patients who underwent living donor liver transplantation
排除标准
- •pediatric patients and repients of dead donor liver transplantation
研究者
相似试验
尚未招募
不适用
Analysis of clinical course after liver transplantation for primary sclerosing cholangitisPrimary sclerosing cholangitisJPRN-UMIN000025336Gastroenterology and Hepatology, Kyoto University45
进行中（未招募）
不适用
PRESERVATION OF RENAL FUNCTION IN LIVER TRANSPLANT RECIPIENTS WITH CERTICAN THERAPY: PROTECT StudyA twelve-month, multicenter, randomized, open-label study of safety, tolerability and efficacy of Certican-based regimen versus calcineurin inhibitor-based regimen in de novo liver transplant recipients - PROTECTEUCTR2005-002920-32-DEovartis Pharma GmbH200
进行中（未招募）
不适用
PRESERVATION OF RENAL FUNCTION IN LIVER TRANSPLANT RECIPIENTS WITH CERTICAN THERAPY: PROTECT StudyA twelve-month, multicenter, randomized, open-label study of safety, tolerability and efficacy of Certican-based regimen versus calcineurin inhibitor-based regimen in de novo liver transplant recipients - PROTECTprophylaxis of organ rejections in adult patients after liver transplantationEUCTR2005-002920-32-ATovartis Pharma GmbH200
进行中（未招募）
1 期
PRESERVATION OF RENAL FUNCTION IN LIVER TRANSPLANT RECIPIENTS WITH CERTICAN THERAPY: PROTECT StudyA twelve-month, multicenter, randomized, open-label study of safety, tolerability and efficacy of Certican-based regimen versus calcineurin inhibitor-based regimen in de novo liver transplant recipients - PROTECTProphylaxis of organ rejections in adult patients after liver transplantationEUCTR2005-002920-32-NLovartis Pharma GmbH
招募中
不适用
Reperfusion Syndrome in liver transplantCTRI/2020/08/026979Center for liver and Biliary Sciences Max Super Speciality Hospital SaketNew DelhiIndia